2.11
price down icon1.86%   -0.04
after-market After Hours: 2.03 -0.08 -3.79%
loading
Sunshine Biopharma Inc stock is traded at $2.11, with a volume of 19,608. It is down -1.86% in the last 24 hours and down -14.57% over the past month. Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.
See More
Previous Close:
$2.15
Open:
$2.15
24h Volume:
19,608
Relative Volume:
0.13
Market Cap:
$5.71M
Revenue:
$32.96M
Net Income/Loss:
$-4.23M
P/E Ratio:
-0.0136
EPS:
-155.3294
Net Cash Flow:
$-14.00M
1W Performance:
-10.97%
1M Performance:
-14.57%
6M Performance:
-24.64%
1Y Performance:
-98.01%
1-Day Range:
Value
$2.04
$2.1732
1-Week Range:
Value
$2.04
$2.4868
52-Week Range:
Value
$2.04
$265.00

Sunshine Biopharma Inc Stock (SBFM) Company Profile

Name
Name
Sunshine Biopharma Inc
Name
Phone
954-515-0810
Name
Address
333 LAS OLAS WAY, FORT LAUDERDALE
Name
Employee
44
Name
Twitter
Name
Next Earnings Date
2024-11-11
Name
Latest SEC Filings
Name
SBFM's Discussions on Twitter

Compare SBFM with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
SBFM
Sunshine Biopharma Inc
2.11 5.71M 32.96M -4.23M -14.00M -155.33
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
161.68 72.40B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.93 47.12B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.19 46.08B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.48 18.88B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
ITCI
Intra Cellular Therapies Inc
131.25 13.96B 612.78M -86.37M -62.91M -0.87

Sunshine Biopharma Inc Stock (SBFM) Latest News

pulisher
Mar 10, 2025

Sunshine Biopharma expands with new gastrointestinal drug By Investing.com - Investing.com Canada

Mar 10, 2025
pulisher
Mar 10, 2025

Sunshine Biopharma expands with new gastrointestinal drug - Investing.com India

Mar 10, 2025
pulisher
Mar 10, 2025

Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market - accessnewswire.com

Mar 10, 2025
pulisher
Mar 04, 2025

Sunshine Biopharma stock hits 52-week low at $2.09 - Investing.com India

Mar 04, 2025
pulisher
Feb 17, 2025

A Look at Sunshine Biopharma Inc (SBFM) Shares in the Recent Past Indicates Growth - SETE News

Feb 17, 2025
pulisher
Jan 28, 2025

Sunshine Biopharma (NASDAQ:SBFMW) Trading 30% Higher – Should You Buy? - Defense World

Jan 28, 2025
pulisher
Jan 26, 2025

Sunshine Biopharma Announces Reverse Stock Split - accessnewswire.com

Jan 26, 2025
pulisher
Jan 26, 2025

Sunshine Biopharma Launches Two New Generic Prescription Drugs - ACCESS Newswire

Jan 26, 2025
pulisher
Jan 25, 2025

Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R) - accessnewswire.com

Jan 25, 2025
pulisher
Jan 25, 2025

Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54% - ACCESS Newswire

Jan 25, 2025
pulisher
Jan 24, 2025

Sunshine Biopharma (NASDAQ:SBFM) Stock Quotes, Forecast and News Summary - Benzinga

Jan 24, 2025
pulisher
Jan 23, 2025

Who’s Hired? Haruvi Returns For A Second Term As AAM Chair - News & Insights

Jan 23, 2025
pulisher
Jan 22, 2025

Sunshine Biopharma launches Olanzapine and Olanzapine ODT - Indian Pharma Post

Jan 22, 2025
pulisher
Jan 21, 2025

Sunshine Biopharma introduces new generic drugs in Canada - MSN

Jan 21, 2025
pulisher
Jan 21, 2025

Sunshine Biopharma Appoints New Chief Commercial Officer - MSN

Jan 21, 2025
pulisher
Jan 21, 2025

Sunshine Biopharma Launches Generic Mental Health Drug in Rapidly Growing Canadian Market - StockTitan

Jan 21, 2025
pulisher
Jan 17, 2025

Sunshine Biopharma Appoints Michel Roy as Chief Commercial Officer - Defense World

Jan 17, 2025
pulisher
Jan 15, 2025

Sunshine Biopharma appoints Michel Roy as CCO - MSN

Jan 15, 2025
pulisher
Jan 15, 2025

Sunshine Biopharma names new Chief Commercial Officer By Investing.com - Investing.com South Africa

Jan 15, 2025
pulisher
Jan 15, 2025

Sunshine Biopharma names new Chief Commercial Officer - Investing.com

Jan 15, 2025
pulisher
Jan 15, 2025

Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer - WICZ

Jan 15, 2025
pulisher
Dec 30, 2024

Sunshine Biopharma, Inc. (NASDAQ:SBFM) Short Interest Down 14.6% in December - Defense World

Dec 30, 2024
pulisher
Dec 11, 2024

Sunshine Biopharma Inc. Elects New Directors and Ratifies Appointment of Independent Registered Public Accounting Firm - Defense World

Dec 11, 2024
pulisher
Dec 10, 2024

Sunshine Biopharma re-elects board, ratifies CPA firm By Investing.com - Investing.com Nigeria

Dec 10, 2024
pulisher
Dec 10, 2024

Sunshine Biopharma re-elects board, ratifies CPA firm - Investing.com India

Dec 10, 2024
pulisher
Dec 10, 2024

Sunshine Biopharma’s PLpro inhibitor shows activity in SARS-CoV-2 - BioWorld Online

Dec 10, 2024
pulisher
Dec 09, 2024

Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus - AccessWire

Dec 09, 2024
pulisher
Dec 09, 2024

Sunshine Biopharma's Novel COVID-19 Oral Treatment Shows Breakthrough Antiviral Activity in Preclinical Study - StockTitan

Dec 09, 2024
pulisher
Dec 04, 2024

Sunshine Biopharma Launches a New Generic Prescription Drug - AccessWire

Dec 04, 2024
pulisher
Dec 04, 2024

Sunshine Biopharma Launches Generic Allergy Drug in $1.3B Global Bilastine Market - StockTitan

Dec 04, 2024
pulisher
Dec 03, 2024

Mouse model studies provide proof of concept for Sunshine Biopharma’s K1.1 mRNA product for HCC - BioWorld Online

Dec 03, 2024
pulisher
Dec 02, 2024

Sunshine Biopharma Announces Breakthrough Research Results on the Company’s K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma - AccessWire

Dec 02, 2024
pulisher
Dec 02, 2024

Sunshine Biopharma's K1.1 mRNA Shows Breakthrough Results in Liver Cancer Treatment - StockTitan

Dec 02, 2024
pulisher
Nov 29, 2024

SBFM (Sunshine Biopharma) Cash From Discontinued Investing Activities : $0.00 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 29, 2024
pulisher
Nov 28, 2024

SBFM (Sunshine Biopharma) Operating Income : $-4.91 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 28, 2024
pulisher
Nov 28, 2024

SBFM (Sunshine Biopharma) Change In Working Capital : $-7.80 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 28, 2024
pulisher
Nov 22, 2024

SBFM (Sunshine Biopharma) Debt-to-Equity : 0.02 (As of Sep. 2024) - GuruFocus.com

Nov 22, 2024
pulisher
Nov 22, 2024

Alkermes (ALKS) Stock Surges Over 5% Amid Strong Financial Perfo - GuruFocus.com

Nov 22, 2024
pulisher
Nov 22, 2024

Stock market today: SKK Holdings Limited +81.83%, Palladyne AI Corp. +50.51% among top gainers in early trading - Business Upturn

Nov 22, 2024
pulisher
Nov 22, 2024

Sunshine Biopharma launches generic prescription drug - TipRanks

Nov 22, 2024
pulisher
Nov 22, 2024

Sunshine Biopharma launches generic liver drug in Canada - Investing.com

Nov 22, 2024
pulisher
Nov 22, 2024

Sunshine Biopharma Launches New Generic Drug in $933M Growing Market | SBFM Stock News - StockTitan

Nov 22, 2024
pulisher
Nov 15, 2024

Sunshine Biopharma stock hits 52-week low at $2.3 amid sharp decline - Investing.com Canada

Nov 15, 2024
pulisher
Nov 13, 2024

Canopy Growth (CGC) Stock Dives Amid Financial Struggles and Ind - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

CRON Experiences Significant Stock Dip Amid Market Volatility - GuruFocus.com

Nov 13, 2024
pulisher
Nov 12, 2024

Sunshine Biopharma Inc. Warrant (SBFMW) Quarterly 10-Q Report - Quartz

Nov 12, 2024
pulisher
Nov 06, 2024

Sunshine Biopharma Q3 Revenue Surges 42% to $8.4M Despite Widening Losses - StockTitan

Nov 06, 2024
pulisher
Nov 06, 2024

SBFM (Sunshine Biopharma) Shares Outstanding (EOP) : 1.17 Mil (As of Jun. 2024) - GuruFocus.com

Nov 06, 2024

Sunshine Biopharma Inc Stock (SBFM) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$10.39
price up icon 3.49%
$33.41
price down icon 2.48%
$100.85
price down icon 3.60%
$109.07
price up icon 1.73%
$9.24
price down icon 1.07%
$131.25
price up icon 0.01%
Cap:     |  Volume (24h):